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Two cDNA clones coding for 2%cr,-glycoprotein (Zn-+gp) have been isolated from a human breast library and their nucleotide sequences 
determined. The deduced amino acid sequence contains the coding information for a hydrophobic signal peptide and the 278 residues of the mature 
protein. Comparison of this sequence with that from the protein purilied from plasma reveals four differences: two amino acid changes (Gin-67 
and Glu-222) and insertion of two residues (He-75 and Phe-76). Northern-blot analysis showed that the Zn-+gp gent is expressed in liver and 
normal breast, but not in placenta, ovary and thyroid. A comparative analysis in mammary tissues from women with different diseases revealed 
enhanced expression of Zn+-gp gene in benign breast lesions and a variable expression level in breast cancers. 
Zn-ew,-glycoprotein: Breast cystic disease: Breast cancer 
1. INTRODUCTION 
Zn-a,-glycoprotein (Zn-a,-gp) is a human protein 
originally isolated from plasma and whose name derives 
from its electrophoretical mobility in the olztregion and 
from its ability to bind zinc ions [l]. The pro\tein shows 
a molecular mass of about 40 kDa, contains 12% carbo- 
hydrates and displays a considerable charge heterogene- 
ity on agarose gel electrophoresis and on isoelectro- 
focusing [2,3]. The complete amino acid sequence of 
human plasma Zn-a,-gp has been recently elucidated 
[4]. It consists of a single polypeptide chain of 276 
amino acid residues, with a high degree of similarity to 
antigens of the major histocompatibility complex. 
tion, we have used these cDNAs as a probe in order to 
study Zn-ol,-gp expression in different normal and pa- 
thological human tissues. 
2 MATERIALS AND METI-iODS 
2. I . Malericils 
Although the biological function of Zn-a,-gp is un- 
known, the finding of high concentrations of this 
protein in cyst fluid from women with gross cystic 
breast disease has suggested that Zn-a,-gp may play a 
role in the induction of the pathological process charac- 
teristic of the disease [5]. In addition, immunohisto- 
chemistry analysis performed on tissue specimens 
obtained from patients with breast carcinoma has led to 
identifying a subtype of tumors which synthesize and 
secrete this protein [6,7]. A better understanding of 
these possible implications of Zn-a,-gp in the develop- 
ment of benign and malignant breast diseases could be 
facilitated by the availability of the gene encoding this 
protein. In this work, we report the isolation and se- 
quencing of cl>NA clones for human Zn-a,-gp. In addi- 
Restriction endonuclcases and other reagents used for molecular 
cloning were obtained from Boehringer-Mannheim. [ol-“?P]dCTP 
(3000 CVmmol), [a-“2P]ATP (3000 Ci/mmol) and [or-35§]dATP (600 
Ci/mmol) were purchased from Amcrsham International. A human 
breast cDNA library in dgt I I was obtained from Clontech Laborato- 
rics Inc, Oligonuclcotidcs were synthcsizcd by the phophoramidite 
method in an Applied Biosystcms DNA synthesizer, model 38lA and 
purified by polyacrylamide gel clcctrophoresis according to standard 
proccdurcs [8]. Double-stranded DNA probes were radiolabeled to 
high specific activity with [cr-“‘P]dCTP by using a commercial ran- 
dom-priming kit from Boehringer-Mannheim. 
2.2. lsolaliorl and cmalwis of cDNA &nes 
Two different oligonucleotides (20-mer) with sequences 
AA(AG)CA(TC)GTNGT(AG)GA(TC)GTMCC and TC(TC)TC(TC) 
TTCCA(AG)TC(TC)TCCAT based on the amino acid sequence of 
Zn-a,-gp (residues 19-25 and 61-66, respectively) were synthesized 
and used to screen a cDNA library made from human breast tissue. 
A total of 5 x IO5 d plaques were analyzed according to the method 
of Benton and Davis [9]. Recombinant phages from isolated positive 
plaques were grown and DNA was prepared from them according to 
Maniatis et al. [8]. The restriction map of inserts was obtained follo- 
wing standard procedures [8]. 
2.3. Sequettce analysis 
Cotwqotrdcwc address; C. L6pez-Otin, Departamento de Biologia 
Funcional, Facultad de Medicina, Universidad de Oviedo, 33006 
Ovicdo, Spain. Fax: (34) (8) 523 2255. 
Restriction fragments were inscrtcd in the polylinker region of 
phage vectors M 13rnp18 or M13mpl9 [IO]. Single-stranded templates 
were isolated and sequenced using either the universal Ml3 primer or 
synthetic oligonucleotide primers and the Sequenase kit (United States 
Biochemical Corp.), The nucleotidesequence was determinded at least 
twice in both strands. The DNA sequences were analysed by computer 
programs DM5 [I I] and ALIGN [I21 on an IBM PC-AT computer. 
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2.4. Preparation and analysis of RNA 
Human tissues were obtained at surgery or from autopsies perfor- 
reed within 15 h after death; human placenta was obtained immedia- 
tely after delivery. Total RNA was isolated according to Chomeczyn- 
ski and Sacchi [13] and samples of about 10 pg were separated by 
electrophoresis in 1.4% agarose denaturing els and blotted onto Hy- 
bond N nylon filters (Amersham International). Filters were prehybri- 
dized for 3 h at 42°C with 50% formamide, 5x SSPE (1 x =150 mM 
NaCI. 10 mM NaH:PO~, I mM EDTA. pH 7,4) 2 × Denhardt's 
solution (I x =0.02% bovine serum albumin. 0.02% polyvinylpyrroli- 
done, 0.02% Ficoll), 0.1% SDS and 0.1 mg/ml of denatured herring 
sperm DNA and then hybridized for 48 h under the same conditions. 
using as a probe the EcoRl fragment 847 bp long which contains the 
3' portion of the Zn.~,-gp eDNA. Filters were washed with 0.2 x SSC 
(1 x SSC is 150 mM NaC1. 15 mM sodium citrate, pH 7), 0.5% SDS 
at 68°C for 2 h and exposed to autoradiography. 
3. RESULTS AND DISCUSSION 
In order to  identify Zn-a2-gp encoding clones, a 
human breast eDNA library was screened with mixed 
oligonueleotides derived from the amino acid sequence 
of the protein. Two out of approximately 5 × 10~/, - 
phage clones were selected on the basis of their strongly 
positive hybridization to the probes. The nucleotide se- 
quence of inserts corresponding to these clones was de- 
termined following the strategy outlined in Fig. I. Both 
eDNA clones shared the same 3' sequence, containing 
the polyadenylation sequence AATAAA and a poly (A) 
tail. However, they presented clear differences in the 
length of their 5' regions. Clone Znl02 was an incom- 
plete eDNA while clone Zn133 contained the complete 
coding information for Zn-ct2-gp. Analysis of nucleotide 
sequence of this latter clone revealed that it contained 
at its 5'-end a region with a high degree of similarity to 
human elongation factor-la, which probably resulted 
from a cloning artifact, 
The nucleotide sequence derived from analysis of the 
different Zn-0c2-gp eDNA clones is shown in Fig.2. The 
sequence includes an open reading frame encoding a 
hydrophobic signal peptide and the 278 residues of the 
mature protein. Comparison of the amino acid sequence 
deduced from the nucleotide sequence with that deter- 
mined for the protein isolated from plasma reveals ome 
discrepancies. There are two substitutions: Gin and Glu 
are present at positions 65 and 222 of the mature poly- 
peptide chain instead of the Glu and Gin residues deter- 
mined at these positions by protein sequencing. In addi- 
tion, we have detected the insertion of an Ile-Phe pair 
between residues located at positions 75 and 76 of the 
previous sequence. These changes could reflect genetic 
polymorphisms, although the possibility of protein se- 
quencmg errors cannot be excluded. 
The nucleotide sequence described herein has also 
provided additional information on the relationship of 
Zn-~t~-gp to human class I major histocompatibility an- 
tigens (HLA). Zn-~_~-gp and HLA antigens how a signi- 
ficant homology at the protein level (36% identities), 
which is also detected in this work at the nucleotide level 
(56% identities to HLA-B7). However, Zn-az-gp lacks 
z .  lo2  
Zn 133 t~{ ~ 
t00 pb 
Fig. 1. Sequencing strategy for the Zn-~z-gp eDNA clones. The restric- 
tion map is shown. Restriction enzymes: B. BamHI; E, EcoRl; (El, 
cloning EcoRl sites; S. Sspl. The boxed region represents he coding 
sequence and the hatched part shows the region coding for the mature 
protein. 
the transmembrane and cytoplasmatic domains cha- 
racteristic of HLA antigens [4]. These domains are re- 
moved by proteolytic enzymes to yield solubilized anti- 
gens, suggesting that Zn-a2-gp might be derived 
through cleavage by proteases present in plasma. How- 
ever, the finding of an in phase stop codon immediately 
adjacent o the Ser residue identified as C-terminal ir~ 
Zn-a2-gp, demonstrates that this protein is not genera- 
ted by a protease.mediated mechanism and suggests 
that Zn-at2-g p may play a role as a soluble HLA-like 
antigen. 
The availability of the eDNA clones allowed us to 
study the expression of the Zn-cz2-gp gene in different 
human tissues. Total RNA was isolated from the collec- 
ted samples and subjected to Northern-blot analysis, 
P G D N V G F N V I( N V 
CC '~CAA~rC,Vd~AAGAA-  z ; : . .  'CTC'rC-C1V..C " • i ,  - 75 
NW A S M ~ R  H L pV  h bS  h L I, h L G p A  
' IG '~GGAGAACCAAGAT~AC'~CCrATATUFACAL~AAGCAT~GA 150 
V P I1~1E N Q D G R g 5 I~ T Y I V T G b g K II V E2D 
_ • ~ - : '~,GG~'IV.~CTCAA'I~,ACL'~AGTIL~AGATACAACAGTAAAGACAGGAA~ 2Z5 
V P ~ F Q A L G S b N D b (~ ~ F R Y N S K D R K S 
,I 8 
~3CAf3CCCATGGCu%C~L~I~ ICtAGACA(~[~]G/u~CP-JkATC43AGG AI~3Cu%A ~ GGA CAGOCAA C~n~ AGAA GGCCAG 300 
Q P I4  G b W ~ Q V E G  H E DW KQ DSQ L I~ K A R 
IE I  73 
GCu~GGACA~A' IX3GAGA~AAAGACATrGTGGAGTA'VrA~ CAtI~TAACVKIG"IL-'rCACC'TA~ 375 
Ev l l -  I f "  ~ v L ~ v I v ~: v v N D s N o s . v Lg~ 
c , t ; c~c~"r  r,3om'r(r t r~c~ lX:C, AC,~'r A,~ C AC, AAC~C,C . ,A~' r  ~ T A a r  A ~ A ~ a ~  ~ 450 
G R F G C E I E N N 0 S S G A F W K Y Y Y D G g D 
123 
CTACAq~I~AAq' I~-~AAC,~TC~ ~ . . ', ~. ".~33AOCCAGCAGOCCAGATAA(X:AA~MGq~3 525 
Y I E F N g g I P A W V P F D P A A (-~ I T K Q g W 
148 
GGA C-C-~C~ A~C~CCA G~r  ACG~3CA GCG(]C~C~GCK~F r A ~ G G A  C~3A ~ C'I~q~/CGG/L~ATA 600 
E A E P V Y V Q R A K A V I, E E E C P A T b R K Y 
173 
CCq~u%AATACAGC A A ~ A A T A ~ A O C G C ~ C t A ~  [~IG~:~[~J~CCAGCCAOC AC4~CCCCA GG 6T5 
L g Y S K N I h D R Q D I 3 P S V V V T S 11 Q A P G 
198 
AC. iAAAAGAAGAAA~~FAUGA~rAOOCAGGGAAAA~I~AL~I~G. , ' I c ' r~GGC/~ 750 
F. g K K L K C h A Y 0 F Y P G K 1 D V II W T R A G 
223 
CGA(IGqU~A~G'~rACGGGC~C~IT(~gI~TI~CAC/L~'PGCukAA~I]GCAL~ACCA , _ ~: -- ' ~25 
E V Q E P E L R G D V h H N G N G T Y Q S W V V V 
I~1 248 
GGCA~AGGACACAGCCCCCFA~ACGTGCAGCACAGCAGCCI~.COCA~r  900 
A V P P Q O T A P Y S C H V ~ H S S b A Q P h V TV 
G(.~CWGGGAGGCCAGCrAGGAAGCAAGG(~ r GAG(~AAIWrGGGATCrCAGACCCA~A~~ 075 
p W E A S * 
278 
TGA~GC~IGAACCACAGAAATCACAGTCAATGGATCCACAAGGCCTGAGGAGCA~CAGAC 1050 
AGGAGGTC~AVI'rGGAGACCGAAGACI~-~C~TC~CrGTcI'rt3AGTAGACr rGGACCCAAAAAA~A' I~A~ I125 
Ca~ACC( IXX:A~TI 'G ' I L~rAATCrGTAOAAGC' rAATAAATAATCA~' r  AAAAAAAAAAA 1105 
Fig. 2. Nucleotide sequence of human breast Zn-e:-gp cDNA, The 
deduced amino acid sequence is shown below the mucleotide sequence 
with numbering starting with residue I of the mature protein, Residues 
which are different in the protein sequence of plasma Zn-~:-gp are 
shown in brackets. The amino acid sequence from the 5'-ttanking 
region with homology to elongation fator 1-~ is shown above the 
nucleotide sequence. The polyadenylation signal is underlined, 
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using as a probe the EcoRI restriction fragment which 
contains the 3’-end of the cDNA. As shown in Fig. 3,a 
single hybridizing band corresponding to a mRNA spe- 
cies of about 1300 nucleotides was identified in breast, 
liver and in both benign and malignant breast tumors. 
The strongest signal was obtained with RNA from pa- 
tients with fibroadenoma, being the result in Fig. 3, a 
representative example of 4 different specimens. Ac- 
cording to this, enhanced expression of %n+-gp could 
be considered as a marker for benign mammary lesions. 
The variable intensity of the band detected at breast 
carcinoma tissues may be related to specific behavioural 
characteristics of the tumors and agrees with immuno- 
histological studies indicating the existence of a subset 
of tumors which maintain the ability to produce this 
protein [b]. 
The molecular basis for the increased levels of Zn-o12- 
gp in benign tumors or in cyst fluid from breast gross 
cystic disease are presently unknown, but the mechan- 
ism is probably mediated by hormonal factors, since 
several data suggest that these lesions result from an 
hormonal imbalance [S]. In relation to this, it is remar- 
kable that 2%&,-gp and other major cyst fluid proteins 
like apolipoprotein D [14] are induced by androgens in 
breast cancer cells [15,16] which suggests that andro- 
gens could be direchtly involved in the enhanced expres- 
sion of 2%a2-gp. 
Brea%t 
ri 
Fig. 3. Expression of Zn-a,-gp mRNA in human tissues. About lO/lg 
of total RNA from the tissues indicated in the upper part of the figure 
were analysed by Northern-blot using a Zn-cr,-gp probe. The positions 
of 25 S- and 18 S-rRNA bands are indicated. 
During the preparation of this manuscript, a report 
describing the characterization of a Zn==a,-gp clone from 
a prostate cDNA library has been published [17]. Exa- 
mination of this nucleotide sequence revealed some 
minor discrepancies with that presented in this work 
(changes at positions 26 and 35 and variable extensions 
at the 3’-flanking region). The absence of data on the 
Y-untranslated sequence precludes a more detailed 
comparison of this region with the corresponding one 
to the breast cDNA clone characterized in this work. 
The isolation and characterization of genomic DNA 
clones containing this part of the gene will be useful to 
elucidate its structure as well as the mechanisms eon- 
trolling the expression of the gene in normal and patho- 
logical breast tissues. 
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